CCK antagonist pre-treatment inhibits meal-enhanced drug absorption in dogs
- 15 January 1997
- journal article
- Published by Elsevier in Regulatory Peptides
- Vol. 68 (1) , 9-14
- https://doi.org/10.1016/s0167-0115(96)00128-0
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Cholecystokinin receptor antagonist MK-329 blocks intestinal fat-induced inhibition of meal-stimulated gastric acid secretionGastroenterology, 1992
- Intestinal Water and Solute Absorption Studies: Comparison of in Situ Perfusion with Chronic Isolated Loops in RatsPharmaceutical Research, 1992
- Effects of CCK receptor blockade on intestinal motor activity in conscious dogsAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 1991
- Nutrient effects on intestinal drug absorptionJournal of Controlled Release, 1990
- Effects of a novel cholecystokinin (CCK) receptor antagonist, MK-329, on gallbladder contraction and gastric emptying in humans. Implications for the physiology of CCK.Journal of Clinical Investigation, 1989
- Effects of food on drug absorptionPharmacology & Therapeutics, 1989
- Clinical Aspects of Cholecystokinin Release and Gallbladder ContractionScandinavian Journal of Gastroenterology, 1989
- Role of cholecystokinin in pancreatic exocrine response to intraluminal amino acids and fatAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 1985
- Correlation of serum phenytoin (diphenylhydantoin) with the administration of oral and intravenous phenytoin in dogsJournal of Veterinary Pharmacology and Therapeutics, 1980